Initiation of coverage by Edison Investment Research | Bourse Reflex
Accueil > Actualités > Communiqués

Initiation of coverage by Edison Investment Research

Mardi 29 Nov 2016 à 18:15

Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of developing new therapies for unsatisfied medical needs in the field of cardiovascular diseases, today announces that Edison Investment Research, an international leading independent investment research company, has just initiated coverage of Quantum Genomics with an initiation note entitled « The next generation of cardiac drugs ».

Edison's initiation note is available on the company's website, www.quantum-genomics.com, in the Equity research section of the Investors tab, which already includes Aurgalys and Invest Securities' ones.

Click here to download Edison's initiation note



CONTACTS
Quantum Genomics

Lionel Ségard
Chairman & Chief Executive Officer
+33 1 85 34 77 77
 
Quantum Genomics
Marc Karako
CFO – Investor Relations
+33 1 85 34 77 75
marc.karako@quantum-genomics.com
 
ACTUS finance & communication (Europe)
Jean-Michel Marmillon
Press Relations
+33 1 53 67 36 73 / jmmarmillon@actus.fr
 
The Ruth Group (U.S.)
Lee Roth / Kirsten Thomas
Investor / Public Relations
+1 646-536-7012 / +1 508-280-6592

 



ABOUT QUANTUM GENOMICS
Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially hypertension and heart failure.
The Company is developing a new therapeutic approach based on BAPAI (Brain Aminopeptidase A Inhibition). This is the result of more than 20 years of academic research in the laboratories of the Collège de France, INSERM, CNRS and the University of Paris Descartes.
Quantum Genomics is listed on the Alternext market in Paris (isin code FR0011648971, Ticker ALQGC).
The Company has offices in Paris, France, and New York, NY, USA. For more information, please visit www.quantum-genomics.com.


Partager sur Facebook
Article Précédent :
Nomination : Nouvelle DSI de Direct...
Article Suivant :
Résultats semestriels 2016/17 :...

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur BourseReflex.com 

Les autres actualités


Retour vers 'Communiqués' »




Mots-clés : New york   Usa   Initiation   Alqgc   Developing   Field   Genomics  
Sociétés citées dans cette news : QUANTUM GENOMICS   Quantum Genomics  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?